Precision Medicine Supply Chain Logistics Market Size, Share & Trends Analysis Report By Type (Clinical), By Service (Transportation), By Temperature Range, By Application (Oncology, Cardiology), By Product, By End-use, By Region, And Segment Forecasts, 2

Precision Medicine Supply Chain Logistics Market Growth & Trends

The global precision medicine supply chain logistics market size is expected to reach USD 14.12 billion by 2030, growing at a CAGR of 11.36% from 2025 to 2030, according to a new report by Grand View Research, Inc. The growth is primarily attributed to the rapid technological advancements, the increasing number of clinical trials, higher approval of precision medicines, and a stringent regulatory framework. In addition, the increasing focus on regulatory compliance towards ensuring the products are handled safely and securely further boosting market growth.

The growth of the precision medicine supply chain logistics industry is driven by the rising demand for personalized medicine, which necessitates highly specialized logistics solutions. As healthcare shifts towards more individualized treatments, precision medicines such as gene therapies, biologics, and personalized drugs require tailored logistics solutions that ensure temperature-controlled transportation, regulatory compliance, and real-time tracking. This shift has created a growing need for end-to-end supply chain management solutions that can handle complex and sensitive products. Advanced technologies such as IoT-based tracking systems, temperature sensors, and blockchain for data transparency are becoming critical for maintaining the integrity of these products throughout the distribution process.

The market growth is also supported by the increasing trend of outsourcing logistics functions to third-party providers, enabling pharmaceutical companies and healthcare organizations to focus on core competencies such as R&D and product development. As the complexity of supply chains grows, outsourcing helps organizations manage logistics more effectively, reducing operational costs and improving scalability. Stringent regulatory requirements, particularly in handling biologics and genetic materials, further contribute to the demand for specialized logistics services that can ensure compliance with local and international regulations. Furthermore, the rise of e-commerce platforms and direct-to-consumer delivery models is expanding the scope of precision medicine logistics, requiring innovative solutions to manage the direct shipment of personalized therapies to patients. These factors are collectively driving the market growth, offering a substantial opportunity for logistics providers to capitalize on this emerging sector.

Rising initiatives by market players play a pivotal role in shaping the precision medicine supply chain logistics landscape. Leading logistics providers and pharmaceutical companies are investing in cutting-edge technologies and infrastructure to enhance the efficiency and reliability of supply chains for personalized treatments. Strategic partnerships and collaborations are being formed to address challenges related to temperature-sensitive shipments, regulatory compliance, and secure data handling. Companies are increasingly focusing on developing integrated logistics solutions that offer end-to-end visibility and real-time monitoring, improving overall supply chain transparency. For instance, in April 2025, GXO initiated a program to test humanoid robots in its warehouses, aiming to integrate advanced AI-driven automation into its operations. The company is currently piloting robots from Agility Robotics, Apptronik, and Reflex Robotics, each performing specific tasks such as moving containers and recycling materials.

Precision Medicine Supply Chain Logistics Market Report Highlights

  • Based on type, the clinical segment dominated the market in 2024, due to an increasing number of research and development activities by the market players, coupled with the growing number of precision medicine therapies in product pipelines.
  • Based on service, the transportation segment dominated the market in 2024. The growth of is largely attributed to the rising demand for efficient, secure, and compliant transportation solutions capable of handling biologics, cell & gene therapies, and personalized medications.
  • Based on temperature range, ambient storage held the largest revenue share in 2024 due to the increasing demand for cell & gene therapies, biologics, and regenerative medicine products that do not require ultra-low or cryogenic temperatures.
  • Based on application, the oncology segment dominated the precision medicine supply chain logistics industry in 2024, due to the rapid adoption of advanced therapies for treating various cancers, particularly hematologic malignancies and solid tumors.
  • Based on product, the cell & gene therapies segment held a dominant revenue share in 2024, due to the rapid advancements in personalized medicine and the increasing adoption of these therapies for a range of complex diseases.
  • Based on end use, pharmaceutical and biopharmaceutical companies held the largest market share in 2024, due to the increasing focus on personalized therapies, including cell and gene therapies, mRNA-based treatments, and other high-value biologics.
Please note The report will be delivered in 2-3 business days upon order notification.


Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Regional Scope
1.1.2. Estimates and Forecast Timeline
1.2. Market Definitions
1.3. Research Methodology
1.3.1. Information Procurement
1.3.2. Purchased Database
1.3.3. GVR’s Internal Database
1.3.4. Secondary Sources
1.3.5. Primary Research
1.4. Information or Data Analysis
1.4.1. Information Analysis
1.4.2. Market Formulation & Data Visualization
1.4.3. Data Validation & Publishing
1.5. Model Details
1.5.1. Commodity Flow Analysis (Model 1)
1.5.2. Value-Chain-Based Sizing & Forecasting (Model 2)
1.5.3. Multivariate Analysis (Model 3)
1.6. List of Secondary Sources
1.7. List of Abbreviations
1.8. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Snapshot
2.3. Competitive Insights Landscape
Chapter 3. Precision Medicine Supply Chain Logistics Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook.
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.1.1. Rising Adoption of Precision Medicine
3.2.1.2. Increasing Clinical Trials for Personalized Therapeutics
3.2.1.3. Regulatory Emphasis on Traceability and Quality Compliance
3.2.2. Market Restraint Analysis
3.2.2.1. High Cost of Specialized Infrastructure and Operational Complexity
3.2.2.2. Limited Standardization and Interoperability Across Supply Chains
3.3. Technology Landscape
3.4. Pricing Model Analysis
3.5. Industry Market Analysis Tools
3.5.1. Porter’s Five Forces Analysis
3.5.2. PESTEL Analysis
3.5.3. COVID-19 Impact Analysis
Chapter 4. Precision Medicine Supply Chain Logistics Market: Type Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. Global Precision Medicine Supply Chain Logistics Market Type Movement Analysis
4.3. Global Precision Medicine Supply Chain Logistics Market Size & Trend Analysis, by Type, 2018 to 2030 (USD Million)
4.4. Clinical
4.4.1. Clinical market estimates and forecasts, 2018 - 2030 (USD Million)
4.5. Commercial
4.5.1. Commercial market estimates and forecasts, 2018 - 2030 (USD Million)
Chapter 5. Precision Medicine Supply Chain Logistics Market: Service Estimates & Trend Analysis
5.1. Segment Dashboard
5.2. Global Precision Medicine Supply Chain Logistics Market Service Movement Analysis
5.3. Global Precision Medicine Supply Chain Logistics Market Size & Trend Analysis, by Service, 2018 to 2030 (USD Million)
5.4. Transportation
5.4.1. Transportation market estimates and forecasts, 2018 - 2030 (USD Million)
5.4.2. Air Freight
5.4.2.1. Air Freight market estimates and forecasts, 2018 - 2030 (USD Million)
5.4.2.2. Sea Freight
5.4.2.2.1. Sea Freight market estimates and forecasts, 2018 - 2030 (USD Million)
5.4.2.3. Overland
5.4.2.3.1. Overland market estimates and forecasts, 2018 - 2030 (USD Million)
5.5. Warehousing
5.5.1. Warehousing market estimates and forecasts, 2018 - 2030 (USD Million)
5.6. Sourcing & Procurement
5.6.1. Sourcing & Procurement market estimates and forecasts, 2018 - 2030 (USD Million)
5.7. Others
5.7.1. Others market estimates and forecasts, 2018 - 2030 (USD Million)
Chapter 6. Precision Medicine Supply Chain Logistics Market: Temperature Range Estimates & Trend Analysis
6.1. Segment Dashboard
6.2. Global Precision Medicine Supply Chain Logistics Market Temperature Range Movement Analysis
6.3. Global Precision Medicine Supply Chain Logistics Market Size & Trend Analysis, by Temperature Range, 2018 to 2030 (USD Million)
6.4. Ambient Storage
6.4.1. Ambient storage market estimates and forecasts, 2018 - 2030 (USD Million)
6.5. Refrigerated Storage
6.5.1. Refrigerated storage market estimates and forecasts, 2018 - 2030 (USD Million)
6.6. Ultra-Low Temperature Storage
6.6.1. Ultra-low temperature storage market estimates and forecasts, 2018 - 2030 (USD Million)
6.7. Cryogenic Storage
6.7.1. Cryogenic storage market estimates and forecasts, 2018 - 2030 (USD Million)
Chapter 7. Precision Medicine Supply Chain Logistics Market: Application Estimates & Trend Analysis
7.1. Segment Dashboard
7.2. Global Precision Medicine Supply Chain Logistics Market Application Movement Analysis
7.3. Global Precision Medicine Supply Chain Logistics Market Size & Trend Analysis, by Application, 2018 to 2030 (USD Million)
7.4. Oncology
7.4.1. Oncology market estimates and forecasts, 2018 - 2030 (USD Million)
7.5. Cardiology
7.5.1. Cardiology market estimates and forecasts, 2018 - 2030 (USD Million)
7.6. Neurology
7.6.1. Neurology market estimates and forecasts, 2018 - 2030 (USD Million)
7.7. Infectious Diseases
7.7.1. Infectious diseases market estimates and forecasts, 2018 - 2030 (USD Million)
7.8. Rare Diseases
7.8.1. Rare diseases market estimates and forecasts, 2018 - 2030 (USD Million)
7.9. Others
7.9.1. Others market estimates and forecasts, 2018 - 2030 (USD Million)
Chapter 8. Precision Medicine Supply Chain Logistics Market: Product Estimates & Trend Analysis
8.1. Segment Dashboard
8.2. Global Precision Medicine Supply Chain Logistics Market Product Movement Analysis
8.3. Global Precision Medicine Supply Chain Logistics Market Size & Trend Analysis, by Product, 2018 to 2030 (USD Million)
8.4. Cell & Gene Therapies (CGT)
8.4.1. Cell & Gene Therapies (CGT) market estimates and forecasts, 2018 - 2030 (USD Million)
8.5. Monoclonal Antibodies
8.5.1. Monoclonal antibodies market estimates and forecasts, 2018 - 2030 (USD Million)
8.6. Nucleic Acid Therapies
8.6.1. Nucleic acid therapies market estimates and forecasts, 2018 - 2030 (USD Million)
8.7. Vaccines
8.7.1. Vaccines market estimates and forecasts, 2018 - 2030 (USD Million)
8.8. Others
8.8.1. Others market estimates and forecasts, 2018 - 2030 (USD Million)
Chapter 9. Precision Medicine Supply Chain Logistics Market: End Use Estimates & Trend Analysis
9.1. Segment Dashboard
9.2. Global Precision Medicine Supply Chain Logistics Market End Use Movement Analysis
9.3. Global Precision Medicine Supply Chain Logistics Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
9.4. Pharmaceutical and Biopharmaceutical Companies
9.4.1. Pharmaceutical and biopharmaceutical companies market estimates and forecasts, 2018 - 2030 (USD Million)
9.5. Clinical Research Organizations
9.5.1. Clinical research organizations market estimates and forecasts, 2018 - 2030 (USD Million)
9.6. Others
9.6.1. Others market estimates and forecasts, 2018 - 2030 (USD Million)
Chapter 10. Precision Medicine Supply Chain Logistics Market: Regional Estimates & Trend Analysis
10.1. Regional Market Share Analysis, 2024 & 2030
10.2. Regional Market Dashboard
10.3. Market Size & Forecasts Trend Analysis, 2018 to 2030 (USD Million)
10.4. North America
10.4.1. North America market estimates and forecasts, 2018 - 2030 (USD Million)
10.4.2. U.S.
10.4.2.1. Key country dynamics
10.4.2.2. Competitive scenario
10.4.2.3. Regulatory framework
10.4.2.4. U.S. market estimates and forecasts, 2018 - 2030 (USD Million)
10.4.3. Canada
10.4.3.1. Key country dynamics
10.4.3.2. Competitive scenario
10.4.3.3. Regulatory framework
10.4.3.4. Canada market estimates and forecasts, 2018 - 2030 (USD Million)
10.4.4. Mexico
10.4.4.1. Key country dynamics
10.4.4.2. Competitive scenario
10.4.4.3. Regulatory framework
10.4.4.4. Mexico market estimates and forecasts, 2018 - 2030 (USD Million)
10.5. Europe
10.5.1. Europe market estimates and forecasts, 2018 - 2030 (USD Million)
10.5.2. UK
10.5.2.1. Key country dynamics
10.5.2.2. Competitive scenario
10.5.2.3. Regulatory framework
10.5.2.4. UK market estimates and forecasts, 2018 - 2030 (USD Million)
10.5.3. Germany
10.5.3.1. Key country dynamics
10.5.3.2. Competitive scenario
10.5.3.3. Regulatory framework
10.5.3.4. Germany market estimates and forecasts, 2018 - 2030 (USD Million)
10.5.4. France
10.5.4.1. Key country dynamics
10.5.4.2. Competitive scenario
10.5.4.3. Regulatory framework
10.5.4.4. France market estimates and forecasts, 2018 - 2030 (USD Million)
10.5.5. Italy
10.5.5.1. Key country dynamics
10.5.5.2. Competitive scenario
10.5.5.3. Regulatory framework
10.5.5.4. Italy market estimates and forecasts, 2018 - 2030 (USD Million)
10.5.6. Spain
10.5.6.1. Key country dynamics
10.5.6.2. Competitive scenario
10.5.6.3. Regulatory framework
10.5.6.4. Spain market estimates and forecasts, 2018 - 2030 (USD Million)
10.5.7. Denmark
10.5.7.1. Key country dynamics
10.5.7.2. Competitive scenario
10.5.7.3. Regulatory framework
10.5.7.4. Denmark market estimates and forecasts, 2018 - 2030 (USD Million)
10.5.8. Norway
10.5.8.1. Key country dynamics
10.5.8.2. Competitive scenario
10.5.8.3. Regulatory framework
10.5.8.4. Norway market estimates and forecasts, 2018 - 2030 (USD Million)
10.5.9. Sweden
10.5.9.1. Key country dynamics
10.5.9.2. Competitive scenario
10.5.9.3. Regulatory framework
10.5.9.4. Sweden market estimates and forecasts, 2018 - 2030 (USD Million)
10.6. Asia Pacific
10.6.1. Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Million)
10.6.2. Japan
10.6.2.1. Key country dynamics
10.6.2.2. Competitive scenario
10.6.2.3. Regulatory framework
10.6.2.4. Japan market estimates and forecasts, 2018 - 2030 (USD Million)
10.6.3. China
10.6.3.1. Key country dynamics
10.6.3.2. Competitive scenario
10.6.3.3. Regulatory framework
10.6.3.4. China market estimates and forecasts, 2018 - 2030 (USD Million)
10.6.4. India
10.6.4.1. Key country dynamics
10.6.4.2. Competitive scenario
10.6.4.3. Regulatory framework
10.6.4.4. India market estimates and forecasts, 2018 - 2030 (USD Million)
10.6.5. Australia
10.6.5.1. Key country dynamics
10.6.5.2. Competitive scenario
10.6.5.3. Regulatory framework
10.6.5.4. Australia market estimates and forecasts, 2018 - 2030 (USD Million)
10.6.6. South Korea
10.6.6.1. Key country dynamics
10.6.6.2. Competitive scenario
10.6.6.3. Regulatory framework
10.6.6.4. South Korea market estimates and forecasts, 2018 - 2030 (USD Million)
10.6.7. Thailand
10.6.7.1. Key country dynamics
10.6.7.2. Competitive scenario
10.6.7.3. Regulatory framework
10.6.7.4. Thailand market estimates and forecasts, 2018 - 2030 (USD Million)
10.7. Latin America
10.7.1. Latin America Market Estimates and Forecasts 2018 to 2030 (USD Million)
10.7.2. Brazil
10.7.2.1. Key country dynamics
10.7.2.2. Competitive scenario
10.7.2.3. Regulatory framework
10.7.2.4. Brazil market estimates and forecasts, 2018 - 2030 (USD Million)
10.7.3. Argentina
10.7.3.1. Key country dynamics
10.7.3.2. Competitive scenario
10.7.3.3. Regulatory framework
10.7.3.4. Argentina market estimates and forecasts, 2018 - 2030 (USD Million)
10.8. MEA
10.8.1. MEA Market Estimates and Forecasts 2018 to 2030 (USD Million)
10.8.2. South Africa
10.8.2.1. Key country dynamics
10.8.2.2. Competitive scenario
10.8.2.3. Regulatory framework
10.8.2.4. South Africa market estimates and forecasts, 2018 - 2030 (USD Million)
10.8.3. Saudi Arabia
10.8.3.1. Key country dynamics
10.8.3.2. Competitive scenario
10.8.3.3. Regulatory framework
10.8.3.4. Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Million)
10.8.4. UAE
10.8.4.1. Key country dynamics
10.8.4.2. Competitive scenario
10.8.4.3. Regulatory framework
10.8.4.4. UAE market estimates and forecasts, 2018 - 2030 (USD Million)
10.8.5. Kuwait
10.8.5.1. Key country dynamics
10.8.5.2. Competitive scenario
10.8.5.3. Regulatory framework
10.8.5.4. Israel market estimates and forecasts, 2018 - 2030 (USD Million)
Chapter 11. Competitive Landscape
11.1. Competition Categorization
11.1.1. Market Leaders
11.1.2. Emerging players
11.2. Company Market Share/Assessment Analysis, 2024
11.3. Company Profiles
11.3.1. Almac Group
11.3.1.1. Company overview
11.3.1.2. Financial performance
11.3.1.3. Service benchmarking
11.3.1.4. Strategic initiatives
11.3.2. Catalent, Inc
11.3.2.1. Company overview
11.3.2.2. Financial performance
11.3.2.3. Service benchmarking
11.3.2.4. Strategic initiatives
11.3.3. Parexel International
11.3.3.1. Company overview
11.3.3.2. Financial performance
11.3.3.3. Service benchmarking
11.3.3.4. Strategic initiatives
11.3.4. IQVIA
11.3.4.1. Company overview
11.3.4.2. Financial performance
11.3.4.3. Service benchmarking
11.3.4.4. Strategic initiatives
11.3.5. Thermo Fisher Scientific
11.3.5.1. Company overview
11.3.5.2. Financial performance
11.3.5.3. Service benchmarking
11.3.5.4. Strategic initiatives
11.3.6. DHL
11.3.6.1. Company overview
11.3.6.2. Financial performance
11.3.6.3. Service benchmarking
11.3.6.4. Strategic initiatives
11.3.7. FedEx
11.3.7.1. Company overview
11.3.7.2. Financial performance
11.3.7.3. Service benchmarking
11.3.7.4. Strategic initiatives
11.3.8. UPS Healthcare
11.3.8.1. Company overview
11.3.8.2. Financial performance
11.3.8.3. Service benchmarking
11.3.8.4. Strategic initiatives
11.3.9. GXO Logistics
11.3.9.1. Company overview
11.3.9.2. Financial performance
11.3.9.3. Service benchmarking
11.3.9.4. Strategic initiatives
11.3.10. Marken
11.3.10.1. Company overview
11.3.10.2. Financial performance
11.3.10.3. Service benchmarking
11.3.10.4. Strategic initiatives

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings